Investigational drug access taken to task in lawsuit against FDA

被引：1

|

作者：

Randal, J

机构：

来源：

JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2003年 / 95卷 / 24期

关键词：

D O I：

10.1093/jnci/95.24.1818

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

收藏

页码：1818 / 1820

页数：3

相关论文

共 50 条

[31] The US FDA is permitting the restricted use of Zelnorm [tegaserod] under a treatment investigational new drug protocol
[J]. Reactions Weekly, 2007, 1163 (1) : 2 - 2
[32] Drug firms lose patent rights lawsuit against South Africa's government
Baleta, A
[J]. LANCET, 2001, 357 (9265): : 1347 - 1347
[33] Pre-Investigational New Drug Meetings With the FDA: Evaluation of Meeting Content and Characteristics of Applications for New Drug and Biologic Products
Vu, Hong H.
Pariser, Anne R.
[J]. THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2015, 49 (03) : 434 - 442
[34] FDA launches public-access database of animal drug approvals
不详
[J]. JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 2008, 233 (09): : 1374 - 1374
[35] How to access and process FDA drug approval packages for use in research
Turner, Erick H.
[J]. BMJ-BRITISH MEDICAL JOURNAL, 2013, 347
[36] FDA warns against ketoconazole use in drug interaction studies
[J]. Reactions Weekly, 2013, 1475 (1) : 2 - 2
[37] FDA panel advises against omeprazole as over the counter drug
Gottlieb, S
[J]. BRITISH MEDICAL JOURNAL, 2000, 321 (7269): : 1099 - 1099
[38] FDA panel advises against cold drug, citing concerns over drug interactions
Cimons, M
[J]. ASM NEWS, 2002, 68 (06): : 263 - 264
[39] US FDA Investigational New Drug approval for first-in-human trial of novel cancer-targeting nanoparticle
不详
[J]. THERAPEUTIC DELIVERY, 2011, 2 (03) : 287 - 287
[40] Clinical studies involving probiotics When FDA's investigational new drug rubric applies-and when it may not
Degnan, Fred H.
[J]. GUT MICROBES, 2012, 3 (06) : 485 - 489

← 1 2 3 4 5 →